Loading…

The effect of Paclitaxel alone and in combination with Cycloheximide on the frequency of premature centromere division in vitro

Premature centromere division (PCD) can be viewed as a manifestation of chromosome instability. In order to evaluate the ability of Paclitaxel (Ptx) and Cycloheximide (Cy) to induce PCD we used a cytokinesis block micronucleus assay (CBMN), fluorescent in situ hybridization (FISH), and the chromosom...

Full description

Saved in:
Bibliographic Details
Published in:Archives of biological sciences 2010, Vol.62 (1), p.63-74
Main Authors: Bajic, V., Galenika a.d., Belgrade (Serbia). Institute of Biomedical Research, Stanimirovic, Z., University of Belgrade, Belgrade (Serbia). Faculty of Veterinary Medicine, Stevanovic, J., University of Belgrade, Belgrade (Serbia). Faculty of Veterinary Medicine, Milicevic, Z., Vinca Institute of Nuclear Sciences, Belgrade (Serbia). Department for Molecular Biology and Endocrinology, Zivkovic, L., University of Belgrade, Belgrade (Serbia). Faculty of Pharmacy, Spremo-Potparevic, B., University of Belgrade, Belgrade (Serbia). Faculty of Pharmacy
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Premature centromere division (PCD) can be viewed as a manifestation of chromosome instability. In order to evaluate the ability of Paclitaxel (Ptx) and Cycloheximide (Cy) to induce PCD we used a cytokinesis block micronucleus assay (CBMN), fluorescent in situ hybridization (FISH), and the chromosome aberration (CA) assay in human peripheral blood lymphocytes. Results showed that Ptx can induce PCD alone or in combination with Cy. These findings call us to pay more attention to PCD as a parameter of genotoxicity in the pre-clinical research of mono- and/or combinational therapies for cancer treatment.
ISSN:0354-4664
1821-4339
DOI:10.2298/ABS1001063B